» Articles » PMID: 29221631

A Population-based Evaluation of the Natural History of Chronic Pancreatitis

Overview
Journal Pancreatology
Date 2017 Dec 10
PMID 29221631
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Based on reports from tertiary care centers, chronic pancreatitis (CP) is considered to be a painful and debilitating disease frequently requiring invasive interventions. Our primary aim was to assess the natural course of CP in a population-based cohort using endoscopic and surgical interventions as surrogates for disease aggressiveness.

Methods: We identified all patients (n = 89, alcoholic [ACP = 46], non-alcoholic [NACP] = 43) with newly diagnosed definite CP from Olmsted County, Minnesota between 1977 and 2006. Patients were followed until death or censoring. Medical records were reviewed at time of diagnosis and during each follow-up. Both lifetime proportions and cumulative incidence since the initial manifestation of CP were estimated and compared. Survival was estimated with Kaplan-Meier methodology.

Results: Median age at CP diagnosis was 56 years (IQR, 48-67) and 56% were male. During median follow-up of 10 years, 68 (76%) experienced pancreatic pain, but only 27 (30%) needed any invasive therapeutic intervention: 23% had endotherapy and 11% had pancreatic surgery. During the clinical course, when compared with NACP, ACP patients had significantly more (all p < 0.05) pain (87 vs. 65%), recurrent acute pancreatitis (44 vs. 23%), pseudocysts (41 vs. 16%), cumulative incidence of exocrine insufficiency (60 vs. 21%), and annual hospitalizations after CP diagnosis (0.79 vs. 0.25). The cumulative risk of diabetes, calcifications, surgery and overall survival was similar in ACP and NACP.

Conclusions: Our study suggests that CP at a population level may have a milder course than that reported from tertiary centers. We confirm that ACP has a more severe phenotype than NACP.

Citing Articles

Decreased Life Expectancy in Patients with Acute and Chronic Pancreatitis.

Munigala S, Subramaniam D, Subramaniam D, Xian H, Munigala S, Kottapalli K Dig Dis Sci. 2025; .

PMID: 40056301 DOI: 10.1007/s10620-025-08944-w.


Minimally invasive versus open lateral pancreaticojejunostomy in patients with painful chronic pancreatitis: systematic review.

Montorsi R, Francken M, Boermeester M, Busch O, Daams F, Hackert T BJS Open. 2025; 9(1).

PMID: 39835446 PMC: 11747668. DOI: 10.1093/bjsopen/zrae135.


European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations.

Dominguez-Munoz J, Vujasinovic M, de la Iglesia D, Cahen D, Capurso G, Gubergrits N United European Gastroenterol J. 2024; 13(1):125-172.

PMID: 39639485 PMC: 11866322. DOI: 10.1002/ueg2.12674.


Impact of Ethno-racial Factors on Clinical Outcomes and Health Care Utilization in Chronic Pancreatitis.

Chhoda A, McHenry N, Liyen Cartelle A, Bocchino R, Kahan T, Shah I J Racial Ethn Health Disparities. 2024; .

PMID: 38702491 DOI: 10.1007/s40615-024-02017-w.


Use of pancreatic endotherapy in patients with chronic pancreatitis: results from a multicenter cohort study in the United States.

Han S, Conwell D, Easler J, Yang Y, Andersen D, Fisher W Gastrointest Endosc. 2024; 100(2):262-272.e1.

PMID: 38583544 PMC: 11528426. DOI: 10.1016/j.gie.2024.04.002.


References
1.
Hirota M, Shimosegawa T, Masamune A, Kikuta K, Kume K, Hamada S . The seventh nationwide epidemiological survey for chronic pancreatitis in Japan: clinical significance of smoking habit in Japanese patients. Pancreatology. 2014; 14(6):490-6. DOI: 10.1016/j.pan.2014.08.008. View

2.
Whitcomb D, Frulloni L, Garg P, Greer J, Schneider A, Yadav D . Chronic pancreatitis: An international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016; 16(2):218-24. PMC: 6042966. DOI: 10.1016/j.pan.2016.02.001. View

3.
Ali U, Issa Y, Bruno M, Goor H, Van Santvoort H, Busch O . Early surgery versus optimal current step-up practice for chronic pancreatitis (ESCAPE): design and rationale of a randomized trial. BMC Gastroenterol. 2013; 13:49. PMC: 3610165. DOI: 10.1186/1471-230X-13-49. View

4.
Glass L, Whitcomb D, Yadav D, Romagnuolo J, Kennard E, Slivka A . Spectrum of use and effectiveness of endoscopic and surgical therapies for chronic pancreatitis in the United States. Pancreas. 2014; 43(4):539-43. PMC: 4122518. DOI: 10.1097/MPA.0000000000000122. View

5.
Howes N, Lerch M, Greenhalf W, Stocken D, Ellis I, Simon P . Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004; 2(3):252-61. DOI: 10.1016/s1542-3565(04)00013-8. View